The Role of Advanced Practice Providers in Treatment Adherence in EGFR-Mutated NSCLC

Narjust Florez, MD, and Stephanie J. McDonald, MSN, FNP-BC, AOCNP, discuss the critical role of advanced practice providers in optimizing adherence to EGFR-targeted therapies in patients with EGFR-mutated non–small cell lung cancer. Florez highlights how consistent patient education, toxicity monitoring, and early intervention contribute to improved treatment persistence and outcomes. McDonald emphasizes the importance of multidisciplinary coordination and longitudinal patient engagement to address barriers to adherence throughout the disease course.